Should Psychedelic Drugs Be Offered as a Treatment for Mental Illness?
Ruoqi Zhang
Journal of Humanities Arts and Social Science March 13, 2023 DOI: 10.26855/jhass.2023.02.010 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Key points | Argues that psychedelics can be a beneficial addition to mental illness treatment for both patients and society, potentially helping with anxiety, depression, PTSD, and bipolar disorder. The authors justify this through three perspectives: the historical use of psychedelics across cultures, evidence on safety and efficacy in therapy, and a call for therapists across disciplines to adopt these therapies. |
Abstract
Psychedelics are becoming increasingly popular as an entry point into difficult- to-treat psychiatric illnesses and a supplement to existing treatments. However, many people view these substances with caution due to increased incidents where they've been used illegally in unsupervised settings. This paper argues that adding psychedelics to the treatment of mental illness can be beneficial for both patients and society as a whole. These drugs could help those who suffer from conditions such as anxiety or depression by providing them with new perspectives on their problems. Additionally, psychedelic therapy may provide psychiatrists with additional options when treating more severe cases of disorders such as PTSD or bipolar disorder. This paper will discuss the clinical effects and physiological processes of action of psychedelic substances, which justifies their use in psychotherapy from three perspectives. First, it will cover the history of these drugs, explaining how they have been used throughout different cultures for centuries. Second, it will examine the safety and efficacy of using psychedelics in therapy. Third, this article provides arguments for why psychedelic therapies should be utilized by therapists across a variety of disciplines.
Citations in the library
Cites 15
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases The Journal of Nervous and Mental Disease March 4, 2014
- Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression Journal of Humanistic Psychology June 19, 2017
- Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology & Therapeutics May 1, 2019
- Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression Journal of Clinical Psychopharmacology December 11, 2015
and 10 more in the library